eli lilly trials retatrutide Retatrutide, the next generation of GLP-1 drug from Lilly, helped participants lose an average of 71.2 pounds and reduce knee arthritis pain in a late-stage clinical trial, the company announced. In Eli Lilly infiltrates anti-obesity market

Who Is Most Likely to Experience This Side Effect

A 2022 study in JAMA Network Open also reported 5.1% weight loss at three months and 9.2% at six months among patients using doses at or below 1 mg weekly

This is a normal and expected response to weight loss, not a side effect of the medication itself

What are the possible side effects of weight loss medications

Furthermore, these agents act on the hypothalamus and other brain regions involved in appetite regulation, decreasing hunger and overall caloric intake

Semaglutide Half-Life: 7 Days Semaglutide has a half-life of approximately 7 days, meaning that after each passing week, roughly half of the remaining drug concentration clears from your system